journal cover

Long-term results of ABO-incompatible kidney transplantation with antigen-specific immunoadsorption and rituximab

Transplantation

Jan 25, 2008

Helena GenbergGunnar Tydén

Download from

Publisher
PubMed

Abstract

ABO-incompatible (ABOi) kidney transplantation has gained a renewed interest during the past years. In 2001, a protocol for ABOi kidney transplantation based on antigen-specific immunoadsorption and rituximab was introduced at our center. In this study long-term graft function using thi...read more

Mentioned in this Paper

Monoclonal Antibodies
Decreased Immunologic Activity [PE]
Blood Group H Type 1 Antigen
Graft Survival
Kidney
Adsorption
Glomerular Filtration Rate
Antigens
Immunosorbents
Transfusion Reaction
Paper Details
References
  • References10
  • Citations31
1
  • References10
  • Citations31
1234

Feeds With Similar Papers

Immunosuppression

Immunosuppression trends for solid organ transplantation have undergone a perceptible shift over the past decade. Discover the latest research on immunosuppression here.

Immune Therapies In Cancer

Immunotherapy in cancer is used to help the immune system fight against invading cancer cells. It is used to slow the progression of the disease and prevent metastasis while enhancing the immune response. There are different types, including monoclonal antibodies and checkpoint inhibitors. Here is the latest research on immune therapies in cancer.

Immune Tolerance

Immune tolerance happens when the immune system is not responsive to a substance or organism and does not elicit an immune response. This is a normal physiological response for some antigens, especially when detecting self from non-self. This has been a potential area of therapy for some disorders. Here is the latest research on immune tolerance.

© 2020 Meta ULC. All rights reserved

Long-term results of ABO-incompatible kidney transplantation with antigen-specific immunoadsorption and rituximab

Transplantation

Jan 25, 2008

Helena GenbergGunnar Tydén

PMID: 18162990

DOI: 10.1097/01.tp.0000296031.41424.f8

Abstract

ABO-incompatible (ABOi) kidney transplantation has gained a renewed interest during the past years. In 2001, a protocol for ABOi kidney transplantation based on antigen-specific immunoadsorption and rituximab was introduced at our center. In this study long-term graft function using thi...read more

Mentioned in this Paper

Monoclonal Antibodies
Decreased Immunologic Activity [PE]
Blood Group H Type 1 Antigen
Graft Survival
Kidney
Adsorption
Glomerular Filtration Rate
Antigens
Immunosorbents
Transfusion Reaction

Feeds With Similar Papers

Immunosuppression

Immunosuppression trends for solid organ transplantation have undergone a perceptible shift over the past decade. Discover the latest research on immunosuppression here.

Immune Therapies In Cancer

Immunotherapy in cancer is used to help the immune system fight against invading cancer cells. It is used to slow the progression of the disease and prevent metastasis while enhancing the immune response. There are different types, including monoclonal antibodies and checkpoint inhibitors. Here is the latest research on immune therapies in cancer.

Related Papers

Paper Details
References
  • References10
  • Citations31
1
  • References10
  • Citations31
1234

Download from

Publisher
PubMed
/papers/long-term-results-of-abo-incompatible-kidney/18162990